Mitsubishi UFJ Asset Management Co. Ltd. Increases Stock Position in GE HealthCare Technologies Inc. $GEHC

Key Points

• Mitsubishi UFJ Asset Management raised its position in GE HealthCare by 4.2% to 993,353 shares, worth about $82.27 million at the end of the quarter.
• GE HealthCare reported quarterly EPS of $0.99 (missing the $1.07 estimate) but revenue beat at $5.13 billion, and set FY2026 guidance of $4.80–$5.00 EPS (analyst consensus ~4.89).
• Company insiders — including CFO James Saccaro and CEO Peter Arduini — bought shares in late April/early May, raising insider ownership to 0.36%, while institutional investors hold about 82.06% of the stock.

Mitsubishi UFJ Asset Management Co. Ltd. raised its position in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC - Free Report) by 4.2% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 993,353 shares of the company's stock after buying an additional 39,970 shares during the quarter. Mitsubishi UFJ Asset Management Co. Ltd. owned about 0.22% of GE HealthCare Technologies worth $82,269,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also added to or reduced their stakes in the company. Temasek Holdings Private Ltd bought a new stake in GE HealthCare Technologies in the 3rd quarter worth about $99,922,000. Locust Wood Capital Advisers LLC increased its holdings in GE HealthCare Technologies by 7.1% in the 3rd quarter. Locust Wood Capital Advisers LLC now owns 2,084,337 shares of the company's stock worth $156,534,000 after buying an additional 137,992 shares in the last quarter. Nan Fung Trinity HK Ltd. bought a new stake in GE HealthCare Technologies in the 3rd quarter worth about $23,206,000. Envestnet Asset Management Inc. increased its holdings in GE HealthCare Technologies by 15.8% in the 3rd quarter. Envestnet Asset Management Inc. now owns 338,914 shares of the company's stock worth $25,452,000 after buying an additional 46,231 shares in the last quarter. Finally, Sound Shore Management Inc CT increased its holdings in GE HealthCare Technologies by 14.6% in the 3rd quarter. Sound Shore Management Inc CT now owns 980,756 shares of the company's stock worth $73,655,000 after buying an additional 125,062 shares in the last quarter. Hedge funds and other institutional investors own 82.06% of the company's stock.

Insiders Place Their Bets

In other GE HealthCare Technologies news, CFO James Saccaro purchased 3,310 shares of the company's stock in a transaction on Friday, May 1st. The stock was acquired at an average cost of $60.60 per share, for a total transaction of $200,586.00. Following the purchase, the chief financial officer directly owned 87,471 shares of the company's stock, valued at $5,300,742.60. This trade represents a 3.93% increase in their position. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, CEO Peter J. Arduini purchased 4,169 shares of the company's stock in a transaction on Thursday, April 30th. The stock was acquired at an average price of $59.92 per share, with a total value of $249,806.48. Following the completion of the purchase, the chief executive officer directly owned 259,424 shares in the company, valued at $15,544,686.08. This trade represents a 1.63% increase in their ownership of the stock. The disclosure for this purchase is available in the SEC filing. Insiders acquired 9,229 shares of company stock worth $556,180 in the last three months. 0.36% of the stock is owned by company insiders.

GE HealthCare Technologies Trading Down 0.6%

Shares of NASDAQ:GEHC opened at $61.34 on Friday. The stock has a 50 day moving average of $71.92 and a 200 day moving average of $77.34. The company has a market cap of $27.90 billion, a PE ratio of 14.67, a price-to-earnings-growth ratio of 1.39 and a beta of 0.74. The company has a current ratio of 1.22, a quick ratio of 0.95 and a debt-to-equity ratio of 0.95. GE HealthCare Technologies Inc. has a 12-month low of $58.75 and a 12-month high of $89.77.

GE HealthCare Technologies (NASDAQ:GEHC - Get Free Report) last posted its quarterly earnings results on Wednesday, April 29th. The company reported $0.99 earnings per share for the quarter, missing the consensus estimate of $1.07 by ($0.08). GE HealthCare Technologies had a return on equity of 20.46% and a net margin of 9.10%.The business had revenue of $5.13 billion during the quarter, compared to the consensus estimate of $5.04 billion. During the same quarter in the previous year, the company earned $1.01 earnings per share. The company's revenue for the quarter was up 7.4% compared to the same quarter last year. GE HealthCare Technologies has set its FY 2026 guidance at 4.800-5.000 EPS. As a group, equities research analysts expect that GE HealthCare Technologies Inc. will post 4.89 EPS for the current year.

GE HealthCare Technologies Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Friday, May 15th. Shareholders of record on Friday, April 3rd will be paid a $0.035 dividend. This represents a $0.14 annualized dividend and a yield of 0.2%. The ex-dividend date is Thursday, April 2nd. GE HealthCare Technologies's dividend payout ratio is presently 3.35%.

Analysts Set New Price Targets

Several equities research analysts recently commented on GEHC shares. Oppenheimer reiterated an "outperform" rating and issued a $85.00 price objective on shares of GE HealthCare Technologies in a report on Thursday, April 30th. JPMorgan Chase & Co. reduced their price objective on GE HealthCare Technologies from $80.00 to $65.00 and set a "neutral" rating for the company in a report on Thursday, April 30th. Wall Street Zen downgraded GE HealthCare Technologies from a "buy" rating to a "hold" rating in a report on Saturday, March 21st. Rothschild & Co Redburn reduced their price objective on GE HealthCare Technologies from $110.00 to $98.00 in a report on Thursday, April 30th. Finally, UBS Group downgraded GE HealthCare Technologies from a "neutral" rating to a "sell" rating and lifted their price objective for the stock from $73.00 to $77.00 in a report on Thursday, January 15th. Eight analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and one has given a Sell rating to the company. According to MarketBeat.com, GE HealthCare Technologies has a consensus rating of "Hold" and a consensus target price of $80.67.

About GE HealthCare Technologies

GE HealthCare Technologies NASDAQ: GEHC is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.

Want to see what other hedge funds are holding GEHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for GE HealthCare Technologies Inc. (NASDAQ:GEHC - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.